Nandini S. Kishore - Concepedia

Author

Nandini S. Kishore

Monsanto (United States)

Also Known As

N S Kishore, N. Kishore, N.S. Kishore, Nandini Kishore, Nandini S. Kishore

Publications

645

Citations

H-Index

Concepts

All Affiliations

Monsanto (United States)Washington University in St. Louis

About

Nandini S. Kishore is an author at Monsanto (United States) specializing in natural sciences, molecular biology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	6	6	336
2	Medicine	5	5	195
3	Biochemistry	5	5	326
4	Engineering	2	2	104
5	Cell Biology	2	2	97

Nandini S. Kishore

Publications

580

Citations

H-Index

Page 1

	Year	Citations
The substrate specificity of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. Analysis of myristic acid analogs containing oxygen, sulfur, double bonds, triple bonds, and/or an aromatic residue Nandini S. Kishore, Tsu‐Shang Lu, Laura J. Knoll, Journal of Biological Chemistry EngineeringAldo-keto ReductaseMolecular BiologyChemical BiologyMyristic Acid Analogs	1991	93
Substrate specificity of Saccharomyces cerevisiae myristoyl-CoA: protein N-myristoyltransferase. Analysis of fatty acid analogs containing carbonyl groups, nitrogen heteroatoms, and nitrogen heterocycles in an in vitro enzyme assay and subsequent identification of inhibitors of human immunodeficiency virus I replication. Balekudru Devadas, Taotao Lu, Akira Katoh, Journal of Biological Chemistry Bioorganic ChemistryVitro Enzyme AssayMolecular BiologyHuman Immunodeficiency VirusChemical Biology	1992	76
Comparison of the acyl chain specificities of human myristoyl-CoA synthetase and human myristoyl-CoA:protein N-myristoyltransferase. Nandini S. Kishore, David C. Wood, Pramod P. Mehta, Journal of Biological Chemistry Acyl Chain SpecificitiesAldo-keto ReductaseMolecular BiologyChemical BiologyProtein Synthesis	1993	73
Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line. Martin L. Bryant, Lee Ratner, Robert J. Duronio, Proceedings of the National Academy of Sciences Viral ReplicationGag PolyproteinImmunologyMolecular BiologyCovalent Linkage	1991	69
Design and Synthesis of Novel Imidazole-Substituted Dipeptide Amides as Potent and Selective Inhibitors of <i>Candida albicans</i> MyristoylCoA:Protein <i>N</i>-Myristoyltransferase and Identification of Related Tripeptide Inhibitors with Mechanism-Based Antifungal Activity Balekudru Devadas, Sandra K. Freeman, Mark E. Zupec, Journal of Medicinal Chemistry	1997	65
Novel Biologically Active Nonpeptidic Inhibitors of MyristoylCoA:Protein <i>N</i>-Myristoyltransferase Balekudru Devadas, Sandra K. Freeman, Charles A. McWherter, Journal of Medicinal Chemistry	1998	50
N-Myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA:protein N-myristoyltransferase Jennifer K. Lodge, Emily Jackson-Machelski, Balekudru Devadas, Microbiology	1997	46
Conformationally Constrained [<i>p</i>-(ω-Aminoalkyl)phenacetyl]-<scp>l</scp>-seryl-<scp>l</scp>-lysyl Dipeptide Amides as Potent Peptidomimetic Inhibitors of <i>Candida albicans</i> and Human Myristoyl-CoA:Protein <i>N</i>-Myristoyl Transferase Srinivasan Nagarajan, Balekudru Devadas, Mark E. Zupec, Journal of Medicinal Chemistry	1997	44
The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulins Nandini S. Kishore, Dulari D. Shah, Verna M. Skanes, Molecular Immunology Fluid-phase BindingImmunogeneticsMolecular ImmunologyGenetic VariantsAutoimmune Disease	1988	28
Synthesis of myristic acid analogs with anti-HIV activity that may be resistant to metabolic processing by β-oxidation Balekudru Devadas, Nandini S. Kishore, Steven P. Adams, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAnti-hiv ActivityAntiviral CompoundBiochemistryMedicine	1993	15

Page 1